TrialThoracic cancer2023

A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01.

Shinji Atagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.